Nektar Therapeutics
NKTR
$0.8968
$0.08149.98%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.39% | -33.75% | -36.69% | -39.88% | -31.80% |
| Total Receivables | -38.10% | -25.05% | 81.40% | -73.20% | -70.26% |
| Inventory | -- | -30.08% | -19.75% | -16.15% | -20.61% |
| Prepaid Expenses | -50.80% | -37.57% | -- | -26.39% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,737.79% | 29.07% | -56.70% | -41.54% | -91.05% |
| Total Current Assets | -28.20% | -33.07% | -34.87% | -39.43% | -33.44% |
|
|
|||||
| Total Current Assets | -28.20% | -33.07% | -34.87% | -39.43% | -33.44% |
| Net Property, Plant & Equipment | -67.88% | -52.63% | -49.85% | -57.08% | -62.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.09% | 161.14% | 231.15% | 106.86% | 94.71% |
| Total Assets | -30.36% | -30.54% | -29.50% | -43.99% | -43.38% |
|
|
|||||
| Total Accounts Payable | 160.86% | 147.23% | 136.93% | -24.13% | -38.30% |
| Total Accrued Expenses | 28.97% | 21.18% | -34.56% | -42.93% | -62.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.62% | 12.70% | 3.17% | 3.17% | 3.17% |
| Total Finance Division Other Current Liabilities | 17.09% | -55.57% | -37.42% | -26.10% | -- |
| Total Other Current Liabilities | 17.09% | -55.57% | -37.42% | -26.10% | -- |
| Total Current Liabilities | 29.69% | 13.08% | -12.48% | -24.83% | -37.95% |
|
|
|||||
| Total Current Liabilities | 29.69% | 13.08% | -12.48% | -24.83% | -37.95% |
| Long-Term Debt | -20.86% | -20.75% | -18.79% | -27.52% | -25.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.10% | -14.23% | -13.42% | -12.68% | -12.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 39.33% | 56.30% | -33.11% | -38.62% | 62.44% |
| Total Liabilities | -8.41% | -11.33% | -16.07% | -22.36% | -23.29% |
|
|
|||||
| Common Stock & APIC | 1.50% | 1.58% | 1.66% | 0.93% | 1.09% |
| Retained Earnings | -4.90% | -5.22% | -5.27% | -8.62% | -9.35% |
| Treasury Stock & Other | 58.36% | 45.83% | 40.10% | 101.16% | 22.24% |
| Total Common Equity | -69.33% | -59.54% | -47.40% | -64.27% | -61.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -69.33% | -59.54% | -47.40% | -64.27% | -61.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -69.33% | -59.54% | -47.40% | -64.27% | -61.34% |
|
|
|||||
